Trial Profile
An open label, single dose, phase I pilot study in healthy volunteers to determine the pharmacokinetic, safety and tolerability profiles of oxycodone delivered from a transdermal oxycodone patch to promote pain relief.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Oxycodone (Primary)
- Indications Pain
- Focus Pharmacokinetics
- 26 Jul 2013 Results reported in a Phosphagenics media release.
- 26 Jul 2013 Primary endpoint 'Pharmacokinetic-parameters' has been met.
- 23 May 2013 Planned End Date changed to 7 Apr 2014 as reported by Australian New Zealand Clinical Trials Registry.